Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2010
04/13/2010US7696417 Inbred corn line IV2
04/13/2010US7696415 Soybean cultivar S07-04KL904015
04/13/2010US7696414 Soybean cultivar S07-04KL019461
04/13/2010US7696412 Genes encoding novel Bacillus thuringiensis proteins with pesticidal activity against Coleopterans
04/13/2010US7696411 Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars
04/13/2010US7696410 Isolated nucleic acid molecule that encodes a polypeptide that confers disease resistance activity of soybean to plant pathogens
04/13/2010US7696409 use of nucleotide sequences in the genetic-engineering of plants to display enhanced nitrogen assimilatory and utilization capacities, grow larger, more efficiently or rapidly, and/or have enriched nitrogen contents in vegetative and/or reproductive plant parts and/or increased biomass
04/13/2010US7696408 Method to enhance Agrobacterium-mediated transformation of plants
04/13/2010US7696407 Proteins and DNA related to salt tolerance in plants
04/13/2010US7696406 includes the provision of a recombinant RNA comprising a complementary copy of coding sequence of a heterologous polypeptide, a complementary copy of an internal ribosome entry site (IRES) and a 3' untranslated region of a positive strand single-stranded RNA virus
04/13/2010US7696405 Zea mays provides a high level of specificity for expression in developing pollen; plants comprising suppressed male fertility genes, useful as females in hybrid plant production; useful for generating fertile parental plants that, when crossed generate sterile progeny plants
04/13/2010US7696404 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
04/13/2010US7696403 Drug screening for an allergosis; screening an inducer/promoter or an inhibitor for Th2-mediated immune response or a promoter or an inhibitor for PIR-A function
04/13/2010US7696345 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
04/13/2010US7696344 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing
04/13/2010US7696343 using antagonists to JAM-1 Claudin-4 and occludin; drug delivery; small interfering nucleic acid (siNA) that down-regulates the expression of a junctional adhesion molecule-1 (JAM-1) rnRNA in a respiratory epithelial cell
04/13/2010US7696339 Nucleic acid encoding monkey QRFP
04/13/2010US7696336 Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
04/13/2010US7696334 viral genomic address messenger genes or (VGAM) genes; selectively inhibit translation of known host target genes; useful in diagnosing, preventing and treating viral disease
04/13/2010US7696333 increased yield in the production of L-lactic acid
04/13/2010US7696332 Replication vector showing cell-specific expression
04/13/2010US7696324 Humanized antibodies
04/13/2010US7696321 Molecules and methods for inhibiting shedding of KIM-1
04/13/2010US7696319 PRO1772 antibodies
04/13/2010US7696318 Host cell protein knock-out cells for production of therapeutic proteins
04/13/2010US7696317 Mammalian genes; related reagents and methods
04/13/2010US7696314 Hypoallergenic mutant polypeptides based on fish parvalbumin
04/13/2010US7696308 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria
04/13/2010US7696180 Antisense oligonucleotide derivative as antitumor agent; biodrugs
04/13/2010US7696179 inhibiting HIV entry into CCR5-expressing cells; treatment and prevention of infectious diseases or disorders, e.g., HIV infection, AIDS, and AIDS-related diseases
04/13/2010US7696173 fusion protein has trypsin and/or chymotrypsin loop being replaced with a vascular endothelial growth factor binding peptide; a culture product; anticarcinogenic agents, antitumor agents; antiinflammatory agent for treating cartilage and bone disorder; treating dermatitis
04/13/2010US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder
04/13/2010US7696157 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression
04/13/2010US7696153 G-CSF conjugates
04/13/2010US7696151 Providing a screening assay having stearoyl-CoA desaturase biological activity, contacting sceening assay with a test compound and measuring the biological activity
04/13/2010US7695969 Genetically engineering preferential bacteria; obtain bacteria that is stable containing desirable output traits, transform with expression vector, monitor bacteria for intensified mutation activity
04/13/2010US7695968 Nucleotide sequences regulating gene expression and constructs and methods utilizing same
04/13/2010US7695966 Method for the separation and sorting of different biological objects utilizing differences in their viscoelastic properties
04/13/2010US7695964 Compositions and methods for generating short double-stranded RNA using mutated RNAse III
04/13/2010US7695962 Polypeptides and nucleic acids encoding same
04/13/2010US7695961 Insulin related transcription factor and uses thereof
04/13/2010US7695960 vaccination directed against the hepatitis C virus (HCV);
04/13/2010US7695959 Delivering an adeno-associated virus vector comprising a nucleotide sequence encoding glutamic acid decarboxylase to cells in specific areas of the brain; Parkinson's Disease, Alzheimer's Disease, Amyloid Lateral Sclerosis, and epilepsy
04/13/2010US7695950 Δ5 desaturase and its use in making polyunsaturated fatty acids
04/13/2010US7695949 Genetic engineered microroganisms; auxotropic mutants; polynucleotide sequences
04/13/2010US7695947 Obtained from Trichoderma; high temperature/ph production; papermaking/bleaching; improved performance at conditions of high temperature and pH
04/13/2010US7695943 growing a recombinant micro-organism in the presence of carbon-containing substance, ; used in liquid detergents as a stabilizing agent for lipases, amylases and proteases as well as "protective softener" in the liquid detergents for dishwashing by hand
04/13/2010US7695940 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
04/13/2010US7695939 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
04/13/2010US7695938 Vectors and recombinant host cells comprising nucleic acid molecules encoding Fibroblast Growth Factor-like polypeptides
04/13/2010US7695936 Knobs and holes heteromeric polypeptides
04/13/2010US7695935 Using modified blood coagulation factor as therapeutic treatment for blood disorders and excessive bleeding due to tissue damage or trauma
04/13/2010US7695933 SM38 nucleic acid molecules
04/13/2010US7695931 Carotenoid hydroxylase gene, method for preparing hydroxylated carotenoid, and novel geranylgeranyl pyrophosphate synthase
04/13/2010US7695920 Methods of screening compounds binding to presynaptic protein CAST
04/13/2010US7695910 preparing a mixture solution of a star-like polyethylene glycol having an epoxy group at its terminal, a hydrophilic cross-linking agent, and a probe, and immobilizing the mixture solution on substrate
04/13/2010US7695907 enables detection and analysis of genes with high degree of sensitivity and high degree of accuracy, and reduction of the size and cost of a gene polymorphism analyzing system
04/13/2010US7695906 generate fewer side products because there is complete restriction enzyme cleavage of the ligated intermediates which also increases the yield of the correct product
04/13/2010US7695905 Magnetic fine particles having lower critical solution temperature
04/13/2010US7695904 Reducing non-target nucleic acid dependent amplifications: amplifying repetitive nucleic acid sequences
04/13/2010US7695902 Contacting test solution containing Rna and enzyme; hybridization
04/13/2010US7695751 Detoxifizyme with activity of transforming aflatoxin and the gene encodes thereof
04/13/2010US7695725 also comprises nucleic acid molecule (modified by contact with a psoralen activated by ultraviolet radiation) encoding non-Listerial antigen; immunogens; antigen presenting cells
04/13/2010US7695724 Recombinant rabies virus compositions
04/13/2010US7695720 target VEGFR2 (KDR/flk-1); for treating and preventing tumors
04/13/2010US7695715 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
04/13/2010US7695713 Isolation and identification of T cells
04/13/2010US7695626 Extraction and winterization of lipids from oilseed and microbial sources
04/13/2010US7695426 Methods for enhancing viability
04/13/2010CA2485687C Isolated polynucleotides and methods of promoting a morphology in a fungus
04/13/2010CA2472280C Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants
04/13/2010CA2449747C Use of fkbp chaperones as expression tool
04/13/2010CA2431308C Regulation of angiogenesis with zinc finger proteins
04/13/2010CA2418848C Cng2b: a novel human cyclic nucleotide-gated ion channel
04/13/2010CA2395781C Detection and treatment of polycystic kidney disease
04/13/2010CA2394229C Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
04/13/2010CA2383372C Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression
04/13/2010CA2372468C Compounds exhibiting an antibiotic activity
04/13/2010CA2350080C Novel serine protease bssp2
04/13/2010CA2348773C Functional antagonists of hedgehog activity
04/13/2010CA2330206C Poly(adp-ribose) polymerase gene
04/13/2010CA2321992C Banana streak virus promoter and detection
04/13/2010CA2318482C Il-18 receptors
04/13/2010CA2314397C Novel peptide, apoep1.b, compositions and uses thereof
04/13/2010CA2304258C Methods of synthesizing polynucleotides by ligation of multiple oligomers
04/13/2010CA2290664C Compounds, preparation and use for transferring nucleic acids into cells
04/13/2010CA2265500C Novel semaphorin gene: semaphorin y
04/13/2010CA2265474C Methods and compositions for the detection of candida spp.
04/13/2010CA2257357C Humanized antibodies with modified glycosylation
04/13/2010CA2244946C Gene expression vectors which generate an antigen specific immune response and methods of using the same
04/13/2010CA2232264C Variants of human recombinant interferon-.gamma. (rhu-ifn-.gamma.) with increased thermal stability
04/13/2010CA2219948C Single chain gonadotropins, dna encoding them and method of producing
04/13/2010CA2203528C Methods and kits using macrophage stimulating protein
04/13/2010CA2200868C Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies
04/13/2010CA2189015C Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
04/13/2010CA2165098C Genomic dna fragments containing regulatory and coding sequences for the .beta.2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments
04/13/2010CA2153593C Compositions and methods for delivery of genetic material
04/13/2010CA2144056C Cd27 ligand
04/13/2010CA2089229C Cd40cr receptor and ligands therefor
04/13/2010CA2077154C Hcmv-specific peptides, agents therefor and the use thereof